New drug aims to ease tough schizophrenia symptoms

NCT ID NCT07565428

Recruiting now Symptom relief Sponsor: Minerva Neurosciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called roluperidone for treating negative symptoms of schizophrenia, like lack of motivation and social withdrawal. About 380 adults with schizophrenia will take the drug or a placebo for 12 weeks to see if symptoms improve. Then, for 40 more weeks, researchers will compare how often symptoms return with roluperidone versus standard antipsychotics.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEGATIVE SYMPTOMS OF SCHIZOPHRENIA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CBH Health, LLC dba CenExel
RECRUITING

Gaithersburg, Maryland, 20877, United States
ForCare Clinical Research
RECRUITING

Tampa, Florida, 33613, United States
Hassman Research Institute, LLC dba CenExel
RECRUITING

Marlton, New Jersey, 08053, United States
Pillar Clinical Research, LLC
RECRUITING

Richardson, Texas, 75080, United States
ProScience Research Group
RECRUITING

Culver City, California, 90230, United States